Related references
Note: Only part of the references are listed.Baveno VII - Renewing consensus in portal hypertension
Roberto de Franchis et al.
JOURNAL OF HEPATOLOGY (2022)
Non-selective beta-blockers in patients with ascites: The complex interplay among the liver, kidney and heart
Luis Tellez et al.
LIVER INTERNATIONAL (2022)
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death
Mathias Jachs et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes
Mathias Jachs et al.
GUT (2021)
Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers A Tailored Approach
Mathias Jachs et al.
CLINICS IN LIVER DISEASE (2021)
Adrenergic regulation of immune cell function and inflammation
Drashya Sharma et al.
SEMINARS IN IMMUNOPATHOLOGY (2020)
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
Candid Villanueva et al.
LANCET (2019)
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
JOURNAL OF HEPATOLOGY (2018)
Stratifying Risk in the Prevention of Recurrent Variceal Hemorrhage: Results of an Individual Patient Meta-Analysis
Agustin Albillos et al.
HEPATOLOGY (2017)
Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites
Rohit Sinha et al.
JOURNAL OF HEPATOLOGY (2017)
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)
Thomas Reiberger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2017)
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy
Tilman Sauerbruch et al.
GASTROENTEROLOGY (2015)
Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding
Adrian J. Stanley et al.
JOURNAL OF HEPATOLOGY (2014)
Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review
Angela Puente et al.
LIVER INTERNATIONAL (2014)
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
Thomas Reiberger et al.
GUT (2013)
Carvedilol for preventing recurrent variceal bleeding: Waiting for convincing evidence
Jaime Bosch
HEPATOLOGY (2013)
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II)
Markus Peck-Radosavljevic et al.
WIENER KLINISCHE WOCHENSCHRIFT (2013)
Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding
Salvador Augustin et al.
HEPATOLOGY (2012)
Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites
Thomas Serste et al.
HEPATOLOGY (2010)
Austrian consensus on the definition and treatment of portal hypertension and its complications
M Peck-Radosavljevic et al.
ENDOSCOPY (2005)
Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis
C Villanueva et al.
JOURNAL OF HEPATOLOGY (2004)
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis
JG Abraldes et al.
HEPATOLOGY (2003)
Share Paper
